For more details on each funding stream please click on the funding stream title.
Research for Patient Benefit (RfPB) |
Lower cost research studies (qualitative, quantitative and mixed) to assess whether new interventions provide benefit for people with htealth and social care needs. |
Health Technology Assessment (HTA) |
Large trials of the effectiveness and cost effectiveness of new treatments and technologies compared with the best available care in real healthcare settings. |
Programme Grants for Applied Research (PGfAR) |
Programmes of inter-related studies to tackle recognised health and social care challenges, often by developing and evaluating complex interventions. |
Invention for Innovation (i4i) |
The technical and commercial development of new healthcare technologies that have potential for adoption in the NHS. |
Efficacy and Mechanism Evaluation (EME) |
Trials of the efficacy of treatments in controlled settings, sometimes using proxy or intermediate measures of health outcome. |
Health Services and Delivery Research Programme (HS&DR) |
The evaluation of innovations in health and social care organisation and delivery to improve service quality, efficiency, experience and access. |
Public Health Research (PHR) |
The evaluation of interventions delivered outside the NHS (eg by local authorities, employers, schools, charities, community organisations) intended to improve population health or to reduce health disparities. |
Policy Research Programme (PRP) |
Research that can directly inform the decision of miniters, the DHSC and other policy-makers involved in planning health and social care. |
Global Health (GH) |
Research for the direct and primary benefit of people in low and middle-income countries. |
NIHR Training Programme |
Training and supporting the best health and care researchers to tackle the complex challenges of the future. |